03/13/2021
Vaccinating NEXT - Beginning March 15, 2021
Beginning March 15, vaccination will be made available to those with certain health conditions, disabilities, illness, living spaces, or work environments that put them at higher risk for serious COVID-19 illness.
Phase 1C
Eligible High-Risk Medical Conditions and Disabilities - Effective March 15
People ages 16-64 can be eligible if they are deemed to be at the very highest risk to get very sick from COVID-19
EITHER because they have one or more of the following severe health conditions:
Cancer, current with weakened immune systemÂÂ
Chronic kidney disease, stage 4 or above
Chronic pulmonary disease, oxygen dependent
Down syndrome
Solid organ transplant, leading to a weakened immune system
Pregnancy
Sickle cell disease
Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies (but not hypertension)
Severe obesity (Body Mass Index ≥ 40 kg/m2)
Type 2 diabetes mellitus with hemoglobin A1c level greater than 7.5%
OR if, as a result of a developmental or other significant, high-risk disability, one or more of the following criteria applies**:
A COVID-19 infection is likely to result in severe life-threatening illness or death; OR
Acquiring COVID-19 will limit the individual’s ability to receive ongoing care or services vital to their well-being and survival; OR
Providing adequate and timely COVID care will be particularly challenging as a result of the individual’s disability.
Additional Eligible Medical Conditions - Effective March 15
Based on what we know at this time, those with the following conditions might be at an increased risk of severe illness from the virus that causes COVID-19; therefore they will also be eligible for COVID-19 vaccine:
Asthma (moderate-to-severe)
Cerebrovascular disease (affects blood vessels and blood supply to the brain)
Cystic fibrosis
Hypertension or high blood pressure
Immunocompromised state (weakened immune system) from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, or use of other immune weakening medicines
Neurologic conditions, such as dementia
Liver disease
Overweight (BMI > 25 kg/m2, but < 30 kg/m2)
Obese (BMI > 30 kg/m2, but < 40 kg/m2)
Pulmonary fibrosis (having damaged or scarred lung tissues)
Thalassemia (a type of blood disorder)
Type 1 diabetes mellitus
Additional Eligible Groups - Effective March 15
Congregate residential settings, such as an incarceratioÂn/detention facilities, homeless shelters, or behavioral health facilities
Includes people experiencing homelessness, who may transition into congregate settings at short noticeÂÂÂ
Public transit workers, including airport workers for commercial airlines (but not private airplanes)
Phase 2 – To be determined